Leeds AI spinout adsilico raises £10M to test medical devices on virtual patients
AI · First reported 26 Oct, 08:30 · Updated 22:06
Leeds-based AI spinout adsilico raised £10 million in a Series A round to expand simulations that assess medical devices using models of diverse virtual patients.
- The University of Leeds spinout’s £10 million Series A was led by PXN Ventures, with existing investors Northern Gritstone and Parkwalk also participating.
- Its Virtual Chimera platform uses generative AI to create virtual hearts and blood vessels from anonymised clinical scans, combined with physics-based simulations of device performance.
- Ads ilico plans to develop its virtual heart models, expand into neurovascular devices and increase its workforce; it has completed projects with heart valve and neurovascular device manufacturers.
Summary written by Lux AI from 1 articles
Source spectrum
Left 0 · Centre 2 · Right 0 of 2 rated sources
Images from the coverage
All coverage
Coverage over time
LeftCentreRight
Articles per hour since first reported, by side.
Ownership
- Unknown 50% (1)
- Corporation 50% (1)
Share of the 2 sources by owner type.